Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-05-27 @ 7:18 AM
Study NCT ID:
NCT02498418
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2015-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACTA/RIFX/2015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None